Current Gene Therapy,
Journal Year:
2024,
Volume and Issue:
25(2), P. 113 - 135
Published: April 27, 2024
Radiotherapy
(RT)
is
an
integral
part
of
treatment
management
in
cancer
patients.
However,
one
the
limitations
this
method
resistance
cells
to
radiotherapy.
These
restrictions
necessitate
introduction
modalities
for
radiosensitization
cells.
It
has
been
shown
that
Noncoding
RNAs
(ncRNAs),
along
with
modifiers,
can
act
as
radiosensitivity
and
radioresistant
regulators
a
variety
cancers
by
affecting
double
strand
break
(DSB),
wnt
signaling,
glycolysis,
irradiation
induced
apoptosis,
ferroptosis
cell
autophagy.
This
review
will
provide
overview
latest
research
on
roles
regulatory
mechanisms
ncRNA
after
RT
Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: Sept. 8, 2022
MiRNAs
are
short
non-coding
RNAs
that
regulate
gene
expression
post-transcriptionally
contributing
to
the
development
of
different
diseases
including
cancer.
The
miR-200
family
consists
five
members,
miR-200a,
miR-200b,
miR-200c,
miR-141,
and
miR-429.
Their
is
dysregulated
in
cancer
tissue
their
level
altered
body
fluids
patients.
Moreover,
levels
members
correlate
with
clinical
parameters
such
as
patients’
survival
which
makes
them
potentially
useful
diagnostic
prognostic
biomarkers.
can
act
either
oncomiRs
or
tumor
suppressor
miRNAs
depending
on
target
genes
role
regulation
key
oncogenic
signaling
pathways.
In
most
types
cancer,
acts
miRNA
regulates
all
features
this
review,
we
summarized
pattern
potential
utility
comprehensively
described
hallmarks
proposed
by
Hanahan
Weinberg
focus
epithelial-mesenchymal
transition,
invasiveness,
metastasis
cells.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 8441 - 8441
Published: May 8, 2023
Changes
in
the
DNA
damage
response
(DDR)
and
cellular
metabolism
are
two
important
factors
that
allow
cancer
cells
to
proliferate.
DDR
is
a
set
of
events
which
recognized,
repair
recruited
site
damage,
lesion
repaired,
responses
associated
with
processed.
In
cancer,
commonly
dysregulated,
enzymes
prone
changes
ubiquitination.
Additionally,
metabolism,
especially
glycolysis,
upregulated
cells,
this
metabolic
pathway
modulated
by
The
ubiquitin-proteasome
system
(UPS),
particularly
E3
ligases,
act
as
bridge
between
since
they
regulate
processes.
Hence,
ligases
high
substrate
specificity
considered
potential
therapeutic
targets
for
treating
cancer.
A
number
small
molecule
inhibitors
designed
target
different
components
UPS
have
been
developed,
several
tested
clinical
trials
human
use.
review,
we
discuss
role
ubiquitination
on
overall
confirm
link
them
through
NEDD4,
APC/CCDH1,
FBXW7,
Pellino1.
addition,
present
an
overview
clinically
implications
their
practical
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 3, 2023
Head
and
neck
squamous
cell
carcinoma
is
a
disease
that
most
commonly
produce
tumours
from
the
lining
of
epithelial
cells
lips,
larynx,
nasopharynx,
mouth,
or
oro-pharynx.
It
one
deadly
forms
cancer.
About
to
two
percent
all
neo-plasm-related
deaths
are
attributed
head
carcinoma,
which
responsible
for
about
six
cancers.
MicroRNAs
play
critical
role
in
proliferation,
differentiation,
tumorigenesis,
stress
response,
triggering
apoptosis,
other
physiological
process.
regulate
gene
expression
provide
new
diagnostic,
prognostic,
therapeutic
options
carcinoma.
In
this
work,
molecular
signaling
pathways
related
emphasized.
We
also
an
overview
MicroRNA
downregulation
overexpression
its
as
diagnostic
prognostic
marker
recent
years,
nano-based
therapies
have
been
explored.
addition,
nanotechnology-based
alternatives
discussed
promising
strategy
exploring
paradigms
aimed
at
improving
efficacy
conventional
cytotoxic
chemotherapeutic
agents
against
attenuating
their
cytotoxicity.
This
article
provides
information
on
ongoing
recently
completed
clinical
trials
based
nanotechnology.
Physics in Medicine and Biology,
Journal Year:
2024,
Volume and Issue:
69(18), P. 18TR01 - 18TR01
Published: Aug. 19, 2024
Radiotherapy
has
played
an
essential
role
in
cancer
treatment
for
over
a
century,
and
remains
one
of
the
best-studied
methods
treatment.
Because
its
close
links
with
physical
sciences,
it
been
subject
extensive
quantitative
mathematical
modelling,
but
complete
understanding
mechanisms
radiotherapy
remained
elusive.
In
part
this
is
because
complexity
range
scales
involved
radiotherapy-from
radiation
interactions
occurring
nanometres
to
evolution
patient
responses
months
years.
This
review
presents
current
status
ongoing
research
modelling
across
these
scales,
including
basic
DNA
damage,
immediate
biological
triggers,
genetic-
patient-level
determinants
response.
Finally,
some
major
challenges
field
potential
avenues
future
improvements
are
also
discussed.
Molecular Therapy — Nucleic Acids,
Journal Year:
2025,
Volume and Issue:
36(2), P. 102500 - 102500
Published: March 5, 2025
Chemoradiotherapy
is
the
standard
of
care
for
many
locally
advanced
cancers,
including
cervical
and
head
neck
but
patients
cannot
tolerate
chemotherapy.
Clinical
trials
have
shown
that
radiotherapy
combined
with
hyperthermia
(thermoradiotherapy)
may
be
equally
effective,
yet
it
yields
a
suboptimal
overall
survival
patients,
emphasizing
need
improvement.
MicroRNAs
(miRNAs),
short
non-coding
RNA
sequences,
are
often
dysregulated
in
cancer
exhibit
significant
potential
as
radiosensitizers
by
targeting
genes
associated
DNA
damage
response.
In
this
study,
high-throughput
miRNA
screening
four
cell
lines
identified
55
miRNAs
sensitizing
potential,
18
validated
across
10
additional
(6
4
neck).
Functional
studies
6
miRNAs,
miR-16,
miR-27a,
miR-181c,
miR-221,
miR-224,
miR-1293,
showed
they
reduced
repair
downregulating
ATM,
DNA-PKcs,
Ku70/80,
RAD51.
Additionally,
differential
expression
miR-224
treatment-sensitive
versus
treatment-resistant
indicated
their
predictive
biomarker
treatment
response
patients.
Conclusively,
study
has
promising
development
sensitizers
thermoradiotherapy
provide
biomarkers
predicting
cancers.
Biomarkers,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 21
Published: April 4, 2025
Adrenocortical
carcinoma
(ACC)
is
a
rare
and
extremely
lethal
endocrine
malignancy
emerging
from
adrenal
cortex,
characterized
by
poor
prognosis.
This
study,
performed
integrated
bioinformatics
to
elucidate
the
underlying
molecular
mechanisms
identify
novel
biomarkers,
validating
them
as
therapeutic
targets
for
ACC
The
RNA-seq
data
across
five
gene
expression
profiles
identified
79
DEGs
through
comparative
analysis
of
normal
specimens.
Functional
enrichment
pathway
analyses
using
DAVID
database
revealed
most
significant
GO
terms
enriched
KEGG
pathways.
PPI
network
was
constructed
utilizing
STRING
database,
followed
module
in
Cytoscape.
Finally,
10
hub
genes
were
including
TAGLN,
LUM,
PDGFRA,
FBLN5,
MMP2,
LAMA2,
DCN,
IGF1,
FBLN1
CXCL12
potential
biomarkers.
Subsequent
survival
confirmed
that
FBLN5
are
significantly
associated
with
patient
survivability.
Furthermore,
TFs-DEGs
miRNAs-DEGs
analyses,
transcriptional
post-translational
regulators.
gene-disease
gene-drug
association,
highlighted
correlated
diseases
their
promising
inhibitors.
In
conclusion,
biomarkers
pathways,
provides
comprehensive
insight
into
mechanisms,
prognosis,
clinical
applications
diagnosis
interventions
ACC.
Nucleic Acids Research,
Journal Year:
2023,
Volume and Issue:
51(22), P. 12224 - 12241
Published: Nov. 11, 2023
Abstract
BRCA1-deficient
cells
have
increased
IRE1
RNase,
which
degrades
multiple
microRNAs.
Reconstituting
expression
of
one
these,
miR-4638–5p,
resulted
in
synthetic
lethality
cancer
cells.
We
found
that
miR-4638-5p
represses
TATDN2,
a
poorly
characterized
member
the
TATD
nuclease
family.
discovered
human
TATDN2
has
RNA
3′
exonuclease
and
endonuclease
activity
on
double-stranded
hairpin
structures.
Given
cleavage
by
difficulty
resolving
R-loops,
we
tested
whether
could
resolve
R-loops.
Using
vitro
biochemical
reconstitution
assays,
bound
to
R-loops
degraded
strand
but
not
DNA
forms
Mg2+-dependent
manner.
Mutations
amino
acids
E593
E705
predicted
Alphafold-2
chelate
an
essential
Mg2+
cation
completely
abrogated
this
R-loop
resolution
activity.
Depleting
cellular
damage
chromosomal
instability.
Loss
poor
replication
fork
progression
presence
Significantly,
is
for
survival
cells,
much
less
so
cognate
BRCA1-repleted
Thus,
propose
novel
target
therapy
cancers.
Translational Oncology,
Journal Year:
2024,
Volume and Issue:
48, P. 102063 - 102063
Published: Aug. 1, 2024
The
aim
of
this
research
was
to
elucidate
the
role
miR-34b
in
cervical
cancer
progression
and
underlying
mechanism
behind
miR-34b-mediated
tumor
suppression.
study
revealed
as
a
senescence
inducer
serves
potential
therapeutic
target
developing
combination
therapy
with
senotherapeutics.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1766 - 1766
Published: Aug. 5, 2024
Genomic
instability
is
one
of
the
main
drivers
tumorigenesis
and
development
hematological
malignancies.
Cancer
cells
can
remedy
chemotherapeutic-induced
DNA
damage
by
upregulating
DNA-repair
genes
ultimately
inducing
therapy
resistance.
Nevertheless,
association
between
genes,
drug
resistance,
disease
relapse
has
not
been
well
characterized
in
acute
lymphoblastic
leukemia
(ALL).
This
study
aimed
to
explore
role
machinery
molecular
mechanisms
which
it
regulated
early-
late-relapsing
pediatric
ALL
patients.
We
performed
secondary
data
analysis
on
Therapeutically
Applicable
Research
Generate
Effective
Treatments
(TARGET)—ALL
expansion
phase
II
trial
198
relapsed
precursor
B-cell
ALL.
Comprehensive
genetic
epigenetic
investigations
147
were
conducted
study.
Gene
expression
was
assessed
using
Microarray
RNA-sequencing
platforms.
alternations,
methylation
status,
miRNA
transcriptome
investigated
for
candidate
genes.
identified
three
ALKBH3,
NHEJ1,
PARP1,
that
upregulated
early
relapsers
compared
late
(p
<
0.05).
Such
upregulation
at
diagnosis
significantly
associated
with
disease-free
survival
overall
precursor-B-ALL
Moreover,
PARP1
accompanied
a
significant
downregulation
its
targeting
miRNA,
miR-1301-3p
=
0.0152),
strongly
linked
poorer
survivals.
Upregulation
particular,
increases
likelihood
children.
The
observation
relative
might
serve
as
valid
rationale
proposing
alternative
treatment
approaches,
such
PARP
inhibitors
chemotherapy.
IntechOpen eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 14, 2023
miRNA-mRNA
interaction
depends
on
multiple
factors
such
as
3’UTR
isoforms,
the
cell
and
tissue-specific
expression
levels
of
RNA-binding
proteins,
sequence
context
around
mRNA
target
site,
other
mechanisms.
Genetic
polymorphisms
within
miRNAs
their
sites
appear
to
be
among
most
important
ones
because
they
influence
mode
outcome
universally
irreversibly.
SNP
disruption
binding
sites,
well
conformational
changes
preventing
access
miRNA
its
are
adopted
credible
mechanistic
explanations
SNP-mediated
effects.
The
occurrence
SNPs
same
miRNA-binding
site
implies
combinatorial
action.
presence
repetitive
(homologous)
for
may
both
enhance
targeting
provide
backup
instead
one
disrupted
by
SNP,
thus
rescuing
functionality.
While
being
underexplored,
genetic
homologous
considered
additional
influencing
miRNA-mediated
regulation
gene
expression.